GPhC registered|Tracked Delivery
Wegovy (Semaglutide)
Active ingredient
Semaglutide
Formulation
Subcutaneous pen injection
Class
GLP-1 receptor agonist
Manufacturer
Novo Nordisk
“Every Wegovy prescription is reviewed personally. We check suitability, interactions, and whether it is the right clinical choice.”
— Younes Mekhalfia, GPhC-registered pharmacist

Wegovy

Semaglutide

A once-weekly GLP-1 injection used as part of a UK pharmacist-led weight management programme, prescribed after clinical review.

£99/ month

0.25mg · Starter · Subscribe & Save · £119 without subscription

Final pricing confirmed at assessment.

Select strength

Your prescriber confirms your Wegovy dose at assessment.

  • Once-weekly pen injection
  • GLP-1 hormone action
  • Refill request reviewed before every supply
  • Free sharps bin and injection guide included
Check eligibility

Free consultation · You’re only charged if treatment is approved

  • GPhC-registered pharmacy
  • UK Licensed Medication
  • Discreet packaging

Transparent pricing

Dose Pricing

Prices are shown per month. Subscribe & Save reduces the monthly cost while keeping every treatment decision under prescriber review.

No automatic dose changes
StrengthFlexibleSubscribe & Save
0.25mg£119£99
0.5mg£129£109
1mg£139£119
1.7mg£179£159
2.4mg£199£179
7.2mg£259£239

Dose changes only proceed after prescriber review of your progress, tolerance, side effects, and updated clinical information. Your treatment plan proceeds only when clinically approved.

How it works

How Wegovy works in the body

  1. Regulates appetite

    Semaglutide mimics GLP-1, a natural gut hormone that signals fullness to the brain — reducing hunger and cravings throughout the day.

  2. Slows gastric emptying

    Food remains in the stomach longer, so smaller portions feel more satisfying and blood sugar rises more slowly after meals.

  3. Backed by years of data

    Semaglutide has been prescribed for type 2 diabetes for over five years, giving it one of the largest real-world safety datasets of any modern weight-management treatment.

Clinical evidence

What the trial data shows

Peer-reviewed evidence for Wegovy, cited and attributed — not reframed as a personal promise.

Randomised controlled trial

STEP-1

Wilding JPH et al., NEJM 2021;384:989–1002

Participants
1,961
Duration
68 weeks
Comparator
vs. placebo, alongside lifestyle intervention

Participants on semaglutide 2.4 mg weekly lost an average of ~14.9% of baseline body weight versus ~2.4% on placebo. Trial participants had BMI ≥ 30, or ≥ 27 with a weight-related comorbidity.

Read the full paper

Trial results do not predict individual outcomes. Your pharmacist will discuss realistic expectations during consultation.

Dosing

Typical dosing schedule

Doses escalate gradually under pharmacist supervision to support tolerability. Your exact plan is set during your consultation.

Typical Wegovy dose escalation schedule
WeekNotes
Weeks 1–4

0.25 mg

Starter dose — primarily for tolerance

Weeks 5–8

0.5 mg

Second escalation step

Weeks 9–12

1.0 mg

Third escalation step

Weeks 13–16

1.7 mg

Fourth escalation step

Weeks 17+

2.4 mg

Maintenance dose — the strength used in STEP-1

Safety profile

Possible side effects

Grouped by frequency. Your pharmacist will review these with you in detail before you start.

Common
  • Nausea (most common in first 2–4 weeks)
  • Diarrhoea
  • Constipation
  • Reduced appetite / early satiety
  • Indigestion or heartburn
  • Injection-site reactions (redness, itch)
Uncommon
  • Vomiting
  • Abdominal pain
  • Fatigue or dizziness
  • Gallbladder disease
  • Hair thinning (associated with rapid weight loss, not the drug itself)
Rare
  • Acute pancreatitis — seek urgent medical advice for severe abdominal pain
  • Severe allergic reaction
  • Hypoglycaemia (mainly if combined with insulin or sulfonylureas)

Not a complete list. Read the Patient Information Leaflet supplied with your medication. Report any suspected side effects to the MHRA Yellow Card scheme.

Eligibility

Is Wegovy right for you?

Usually suitable for

  • Adults (18+) with BMI ≥ 30, or ≥ 27 with a weight-related condition
  • Patients who have attempted lifestyle-led weight management without sustained effect
  • Patients able to administer a once-weekly subcutaneous injection
  • Patients who can attend follow-up pharmacist reviews as part of the programme

Not suitable if you are / have

  • Pregnancy, planning pregnancy, or breastfeeding
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome
  • Active severe gastrointestinal disease (e.g. gastroparesis, severe IBD)
  • History of acute pancreatitis
  • Type 1 diabetes (off-label for weight management)
  • Age under 18 years

This is a summary, not a complete assessment. A pharmacist reviews your full health history during consultation before any prescription is issued.

What’s included

Everything in your welcome kit

  • 01Wegovy FlexTouch pen (one month supply)
  • 02Novofine Plus pen needles (4 mm)
  • 03Yellow sharps bin — first bin free, replacement free on request
  • 04Injection technique guide + cold-chain handling card
  • 05Direct pharmacist chat through your dashboard
Younes Mekhalfia - independent prescribing pharmacist
Independent Prescribing Pharmacist

Dispensed & Checked by Us

Unlike other online services, we don’t outsource your care. Every prescription is reviewed, dispensed, and packed by our UK-based clinical team. You’re not just a number - you’re a patient we’re committed to supporting.

“Each consultation is reviewed by a qualified prescriber within their clinical scope before any prescription treatment is supplied.”

— Younes Mekhalfia, Independent Prescribing Pharmacist

Every order

Clinical Review

In-house

UK Dispensing

Individual

Clinical Support

Real humans

Support

Everything you need to know about Wegovy

Find answers about treatment, safety and the service journey.

What is Wegovy?

Wegovy is a once-weekly injection containing Semaglutide, approved specifically for weight management. It's the same active ingredient used in diabetes medications but at doses optimised for weight loss.

Is Wegovy the same as Ozempic?

Both contain semaglutide, but they are licensed for different uses. Ozempic is licensed for type 2 diabetes; Wegovy is licensed specifically for weight management. The two products use different dose ranges — your pharmacist can explain which is appropriate for your clinical context.

How does Wegovy work?

It mimics the hormone GLP-1, which regulates appetite. It signals your brain that you are full and slows down stomach emptying, so you feel satisfied with less food and experience fewer cravings.

What does the clinical trial data show?

In the STEP-1 randomised controlled trial (Wilding et al., New England Journal of Medicine, 2021), participants on semaglutide 2.4mg weekly lost an average of around 15% of baseline body weight over 68 weeks versus roughly 2.4% on placebo. Trial results do not predict individual outcomes — your pharmacist will discuss realistic expectations as part of your consultation, taking into account your starting weight, health profile, and lifestyle.

Is Wegovy proven safe?

Yes. Semaglutide has been used safely for over a decade (originally for diabetes) and has extensive long-term safety data. It's one of the most studied weight loss medications available.

Why choose Wegovy over Mounjaro?

Wegovy has been on the market longer and has more long-term safety data available. Some patients also prefer the "FlexTouch" pen mechanism. It's an excellent choice for those who value established, proven medications.

Can I take Wegovy if I don't have diabetes?

Yes. Wegovy is specifically licensed for weight management in people without diabetes who have a BMI over 30 (or 27 with weight-related health conditions like high blood pressure).

What is the Wegovy FlexTouch pen?

It is a pre-filled pen that contains 4 weekly doses. You attach a needle, dial the dose, and inject. The FlexTouch mechanism is designed for ease of use and consistent dosing.

What are the dosage steps?

0.25mg (Month 1), 0.5mg (Month 2), 1.0mg (Month 3), 1.7mg (Month 4), and 2.4mg (Maintenance). This gradual increase helps minimise side effects while your body adjusts.

Do I have to increase the dose every month?

Not necessarily. If your pharmacist is satisfied with your clinical response at 1.0mg or 1.7mg and you are experiencing side effects, the escalation can be paused or slowed. Finding a well-tolerated dose matters more than following a rigid schedule.

What if I forget to take it?

If it's within 5 days of your missed dose, take it as soon as you remember. If more than 5 days have passed, skip it and wait for your next scheduled day. Never double up on doses.

Where do I inject?

The best sites are the front of your thighs, your stomach (avoiding the belly button area), or your upper arms. Rotate your injection site each week to prevent skin irritation.

Do I need to pinch the skin?

We recommend pinching a fold of skin if you are injecting into the stomach to ensure you inject into fat tissue, not muscle. This makes the injection more comfortable and effective.

How do I dispose of the needles?

Your Caremacy care pack includes a yellow Sharps Bin. Put used needles in there immediately after injection. Never put needles in the household bin or recycling.

Can I switch from Saxenda to Wegovy?

Yes. Since Wegovy is weekly and Saxenda is daily, many patients switch for convenience. You typically wait 24 hours after your last Saxenda shot before starting Wegovy at the 0.25mg dose.

Still have questions? Our pharmacist team is here to help.

Contact us

Your health shouldn’t wait.

Free consultation, pharmacist-reviewed, discreet delivery.

Start your consultation